Named on 2 rounds in the feed, most often in Healthtech.
Rounds from 2022-12-14 to 2026-04-16
ROUNDS
2
led 1, joined 1
LED ROUNDS · USD
$5M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
7
named beside it
Named on 2 rounds in the feed, most often in Healthtech.
Rounds from 2022-12-14 to 2026-04-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
STORM Therapeutics STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas. | Series C Verified against 1 of 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $56M | 2026-04-16 | [ PART ] |
STORM Therapeutics STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2022-12-14 | [ LEAD ] |